BR112012032333A2 - composto, uso de um composto, composição farmacêutica, combinação de um composto e dispositivo - Google Patents

composto, uso de um composto, composição farmacêutica, combinação de um composto e dispositivo

Info

Publication number
BR112012032333A2
BR112012032333A2 BR112012032333A BR112012032333A BR112012032333A2 BR 112012032333 A2 BR112012032333 A2 BR 112012032333A2 BR 112012032333 A BR112012032333 A BR 112012032333A BR 112012032333 A BR112012032333 A BR 112012032333A BR 112012032333 A2 BR112012032333 A2 BR 112012032333A2
Authority
BR
Brazil
Prior art keywords
compound
combination
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
BR112012032333A
Other languages
English (en)
Inventor
Antonio Caligiuri
Gabriele Amari
Mauro Riccaboni
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of BR112012032333A2 publication Critical patent/BR112012032333A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BR112012032333A 2010-06-22 2011-05-30 composto, uso de um composto, composição farmacêutica, combinação de um composto e dispositivo BR112012032333A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10166898 2010-06-22
PCT/EP2011/058801 WO2011160918A1 (en) 2010-06-22 2011-05-30 Alkaloid aminoester derivatives and medicinal composition thereof

Publications (1)

Publication Number Publication Date
BR112012032333A2 true BR112012032333A2 (pt) 2016-11-08

Family

ID=43303945

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012032333A BR112012032333A2 (pt) 2010-06-22 2011-05-30 composto, uso de um composto, composição farmacêutica, combinação de um composto e dispositivo

Country Status (11)

Country Link
US (1) US8629160B2 (pt)
EP (1) EP2585457B1 (pt)
KR (1) KR20130111968A (pt)
CN (1) CN102947298B (pt)
AR (1) AR081965A1 (pt)
BR (1) BR112012032333A2 (pt)
CA (1) CA2803416A1 (pt)
ES (1) ES2545812T3 (pt)
HK (1) HK1181047A1 (pt)
RU (1) RU2569846C2 (pt)
WO (1) WO2011160918A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2206712A1 (en) 2008-12-23 2010-07-14 CHIESI FARMACEUTICI S.p.A. "Alkaloid aminoester derivatives and medicinal composition thereof"
CA2803459A1 (en) * 2010-06-22 2011-12-29 Chiesi Farmaceutici S.P.A. Alkaloid aminoester derivatives and medicinal compositions thereof
RU2585767C2 (ru) 2010-11-26 2016-06-10 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Производные глицина и их применение в качестве антагонистов мускариновых рецепторов
CN104011043B (zh) 2011-12-30 2016-11-16 奇斯药制品公司 作为抗毒蕈碱剂的1-氮杂杂环基乙酸的奎宁环酯、它们的制备方法及其药用组合物
US9427376B2 (en) 2013-10-10 2016-08-30 Chiesi Farmaceutici S.P.A. Process for preparing pharmaceutical formulations for inhalation comprising a high-dosage strength active ingredient

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2824106A (en) * 1958-02-18 Quaternary tropeine compounds and a process of making same
US2856407A (en) * 1956-08-08 1958-10-14 Lakeside Lab Inc Aminoacid esters of n-substituted 3 and 4-piperidinols
GB8923590D0 (en) * 1989-10-19 1989-12-06 Pfizer Ltd Antimuscarinic bronchodilators
US6169075B1 (en) * 1996-09-10 2001-01-02 British Biotech Pharmaceuticals Limited Cytostatic agents
JP2001520222A (ja) * 1997-10-22 2001-10-30 ゼネカ・リミテッド イミダゾール誘導体およびファルネシルタンパク質トランスフェラーゼインヒビターとしてのそれらの使用
IL156499A0 (en) * 2000-12-22 2004-01-04 Almirall Prodesfarma Ag Quinuclidine carbamate derivatives and their use as m3 antagonists
MXPA04006206A (es) 2001-12-20 2004-12-06 S A L V A T Lab Sa Derivados de 1-alquil-azoniabiciclo(2.2.2(octano carbamato y su uso como antagonistas del receptor musrcarinico.
GB0424284D0 (en) * 2004-11-02 2004-12-01 Novartis Ag Organic compounds
EP1882691A1 (en) * 2006-07-26 2008-01-30 CHIESI FARMACEUTICI S.p.A. Quinuclidine derivatives as M3 antagonists
GB0621830D0 (en) * 2006-11-02 2006-12-13 Chroma Therapeutics Ltd Inhibitors of p38 mitogen-activated protein kinase
TW200825084A (en) * 2006-11-14 2008-06-16 Astrazeneca Ab New compounds 521
ES2385681T3 (es) * 2006-12-19 2012-07-30 Astrazeneca Ab Derivados de quinuclidinol como antagonistas de receptores muscarínicos
WO2008075006A1 (en) * 2006-12-19 2008-06-26 Astrazeneca Ab Piperldinum compounds for treatment of obstructive pulmonary diseases ( copd)
EP2154136A1 (en) 2008-08-08 2010-02-17 CHIESI FARMACEUTICI S.p.A. Quinuclidine carbonate derivatives and medicinal compositions thereof
EP2206712A1 (en) 2008-12-23 2010-07-14 CHIESI FARMACEUTICI S.p.A. "Alkaloid aminoester derivatives and medicinal composition thereof"
EP2585458B1 (en) * 2010-06-22 2015-01-07 Chiesi Farmaceutici S.p.A. Alkaloid aminoester derivatives and medicinal compositions thereof
AU2011269238A1 (en) * 2010-06-22 2013-01-10 Chiesi Farmaceutici S.P.A. Dry powder formulation comprising an antimuscarinic drug
CA2803459A1 (en) * 2010-06-22 2011-12-29 Chiesi Farmaceutici S.P.A. Alkaloid aminoester derivatives and medicinal compositions thereof
US20120220557A1 (en) * 2011-02-17 2012-08-30 Chiesi Farmaceutici S.P.A. Liquid propellant-free formulation comprising an antimuscarinic drug

Also Published As

Publication number Publication date
CN102947298A (zh) 2013-02-27
EP2585457A1 (en) 2013-05-01
US20110311461A1 (en) 2011-12-22
US8629160B2 (en) 2014-01-14
AR081965A1 (es) 2012-10-31
RU2012155690A (ru) 2014-06-27
HK1181047A1 (zh) 2013-11-01
ES2545812T3 (es) 2015-09-16
WO2011160918A1 (en) 2011-12-29
CA2803416A1 (en) 2011-12-29
RU2569846C2 (ru) 2015-11-27
CN102947298B (zh) 2016-03-02
EP2585457B1 (en) 2015-07-22
KR20130111968A (ko) 2013-10-11

Similar Documents

Publication Publication Date Title
BR112013008259A2 (pt) composto, composição farmacêutica, e, uso de um composto
BR112013015397A2 (pt) composto, composição farmacêutica, e, uso de um composto
BR112014001255A2 (pt) composto, uso de um composto, combinação, e, composição farmacêutica
BRPI1008793A2 (pt) composto, uso de um composto, e, composição farmacêutica
BRPI1016219A2 (pt) composto, composição farmacêutica, e, uso de um composto
BR112013030302A2 (pt) composto, composição farmacêutica, uso de um composto, combinação de um composto e dispositivo
BR112014013760A2 (pt) composto, composição farmacêutica e uso de um composto
BR112015000420A2 (pt) composto, composição farmacêutica, e, uso de um composto
BR112014029530A2 (pt) compostos, composição farmacêutica e uso de um composto
BR112014029115A2 (pt) composto, composição farmacêutica, e, uso de um composto ou composição
BR112014005669A2 (pt) composto, composição farmacêutica e uso de um composto
BR112012031226A2 (pt) composto, uso do composto, composição farmacêutica, e uso de composição farmacêutica
BRPI1007018A2 (pt) composto, composição farmacêutica, e , uso de um composto.
BRPI0919942A2 (pt) Composto, composição farmacêutica, e, uso de um composto
BRPI0907562A2 (pt) composto, composição farmacêutica, e, uso de um composto
BRPI0921375A2 (pt) composto, composição farmacêutica, e, uso de um composto
BR112014003567A2 (pt) composto, uso de um composto, e, composição farmacêutica
BRPI1008906A2 (pt) composto, composição farmacêutica, e, uso de um composto.
BR112013011448A2 (pt) composto, composição farnmacêutica, e, uso do composto
BRPI0921879A2 (pt) composto, composição farmacêutica , e, uso de um composto
BR112014009471A2 (pt) compostos, combinação de um composto, composição farmacêutica, uso de um composto, dispositivo e kit
BR112014013177A2 (pt) composto, composição farmacêutica e uso de um composto
BR112014029642A2 (pt) composto, combinação de um composto, composição farmacêutica, uso de um composto, dispositivo e kit
BR112014013178A2 (pt) composto, composição farmacêutica e uso de um composto
BRPI0906937A2 (pt) composto, composição farmacêutica, e, uso de um composto

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]